Creo Medical Group (LSE:CREO) EV-to-EBIT : -4.56 (As of Jun. 25, 2024)

Creo Medical Group EV-to-EBIT Chart

Creo Medical Group Annual Data
	Trend	Feb14	Feb15	Feb16	Jun17	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial				-10.32	-11.75	-7.90	-1.45	-6.47

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial												-7.90	-	-1.45	-	-6.47

Competitive Comparison of Creo Medical Group's EV-to-EBIT

For the Medical Devices subindustry, Creo Medical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's EV-to-EBIT falls into.

Creo Medical Group EV-to-EBIT Calculation

Creo Medical Group's EV-to-EBIT for today is calculated as:

Creo Medical Group's current Enterprise Value is £109.99 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creo Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-24.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group  (LSE:CREO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Creo Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Creo Medical Group's Enterprise Value for the quarter that ended in Dec. 2023 was £155.98 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creo Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-24.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (LSE:CREO) Business Description